Search Results

Leflunomide 100mg 100mg  | Purity Not Available

Adooq Bioscience

Leflunomide is a pyrimidine synthesis inhibitor belonging to the DMARD (disease-modifying antirheumatic drug) class of drugs. Leflunomide is used to relieve symptoms caused by rheumatoid arthritis, such as inflammation, swelling, stiffness, and joint pain.

More Information Supplier Page

LDE225 50mg 50mg  | Purity Not Available

Adooq Bioscience

LDE225 (NVP-LDE225) is a potent, selective and orally bioavailable Smoothened (SMO) antagonist that inhibits hedgehog (Hh) signaling pathway via antagonism of the Smoothened receptor (SMO).

More Information Supplier Page

LDE225 5mg 5mg  | Purity Not Available

Adooq Bioscience

LDE225 (NVP-LDE225) is a potent, selective and orally bioavailable Smoothened (SMO) antagonist that inhibits hedgehog (Hh) signaling pathway via antagonism of the Smoothened receptor (SMO).

More Information Supplier Page

LDE225 (NVP-LDE225) 10mM * 1mL in DMSO 10mM * 1mL in DMSO  | Purity Not Available

Adooq Bioscience

LDE225 (NVP-LDE225) is a potent, selective and orally bioavailable Smoothened (SMO) antagonist that inhibits hedgehog (Hh) signaling pathway via antagonism of the Smoothened receptor (SMO).

More Information Supplier Page

LDE225 100mg 100mg  | Purity Not Available

Adooq Bioscience

LDE225 (NVP-LDE225) is a potent, selective and orally bioavailable Smoothened (SMO) antagonist that inhibits hedgehog (Hh) signaling pathway via antagonism of the Smoothened receptor (SMO).

More Information Supplier Page

LDE225 10mg 10mg  | Purity Not Available

Adooq Bioscience

LDE225 (NVP-LDE225) is a potent, selective and orally bioavailable Smoothened (SMO) antagonist that inhibits hedgehog (Hh) signaling pathway via antagonism of the Smoothened receptor (SMO).

More Information Supplier Page

LBH589 50mg 50mg  | Purity Not Available

Adooq Bioscience

LBH589 is a hydroxamic acid and acts as a non-selective HDAC inhibitor with IC5o of HDAC1 to be 0.23 nM.

More Information Supplier Page